ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,499, issued on Aug. 19, was assigned to KEIO UNIVERSITY (Tokyo) and BIOMX LTD. (Nes Ziona, Israel).
"Bacteriophage for modulating inflammatory bowel disease" was invented by Kenya Honda (Tokyo), Koji Atarashi (Tokyo), Seiko Narushima (Tokyo), Efrat Khabra (Petach Tikva, Israel), Hava Ben David (Rehovot, Israel), Eyal Weinstock (Kfar Shmaryahu, Israel), Yulia Matiuhin (Pardes Chana-Karkur, Israel) and Naomi Bluma Zak (Jerusalem).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are bacteriophage compositions and therapeutic uses thereof. The disclosure also relates to bacteriophage that are capable of lysing Klebsiella bacterial strains,...